While significant progress has been made in developing treatments for rare diseases—highlighted by the approval of over 800 ...

By embracing a mix of co-innovation and best practices, stakeholders can boost productivity, streamline clinical trials, and ...

DHA R&D-MRDC researchers are applying the latest regulatory guidance related to AI to better carry out their mission to ...

This new process for endocytic drugs represents a paradigm shift ... which his laboratory continues to explore. He said the ...

After a 20% cut to the FDA’s workforce, biotechs and pharmas are bracing for delays. But the impacts won’t be consistent.

Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing ...

In recent weeks, biotech companies have faced setbacks in moving forward with clinical trials due to operational delays at the FDA, according to an exclusive report from The Wall Street Journal ...

Animal testing requirements for monoclonal antibodies and other medications will be “reduced, refined or potentially replaced ...

It is now possible to obtain three-dimensional, high-resolution images of enzyme activity in tissue samples or whole ...

This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...